Bruce Anderson

Process Chemistry

Bruce Anderson

Bruce began his career as a process chemist at Pfizer's Central Research Center in Groton, Connecticut developing safe, economical, and scalable routes of synthesis for active pharmaceutical ingredients (API's). He then joined Ilex Oncology in San Antonio, Texas to manage the pilot plant producing (API's) to support clinical trials. After the acquisition of Ilex by Genzyme, Bruce transitioned back into process research and development of API's. In his role, Bruce has led the effort for optimizing the pH-sensitive capsule coatings as well as the formulation work at Rani Therapeutics.